Statistics
Publications
9
Citations
449
H-Index
9
Active since
1999
Affiliations
Bayer (United States)(Current)
Robert Sibley is an author at Bayer (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.
Publications per year
1999–2021
9
9
Discovery of a new class of p38 kinase inhibitors
Jacques Dumas, Robert Sibley, Bernd Riedl et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 47 citations · Full text
1–5 of 9